Fractyl Health, Inc. (GUTS)
NASDAQ: GUTS · Real-Time Price · USD
0.4655
-0.0040 (-0.85%)
At close: Mar 13, 2026, 4:00 PM EDT
0.4599
-0.0056 (-1.20%)
After-hours: Mar 13, 2026, 7:58 PM EDT
Fractyl Health Employees
Fractyl Health had 101 employees as of September 30, 2025. The number of employees decreased by 21 or -17.21% compared to the same quarter last year.
Employees
101
Change
-21
Growth
-17.21%
Revenue / Employee
$30
Profits / Employee
-$1,209,871
Market Cap
63.79M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 101 | -21 | -17.21% |
| Jun 30, 2025 | 103 | -9 | -8.04% |
| Mar 31, 2025 | 109 | -2 | -1.80% |
| Dec 31, 2024 | 107 | 5 | 4.90% |
| Sep 30, 2024 | 122 | 34 | 38.64% |
| Jun 30, 2024 | 112 | 19 | 20.43% |
| Mar 31, 2024 | 111 | 18 | 19.35% |
| Dec 31, 2023 | 102 | - | - |
| Sep 30, 2023 | 88 | - | - |
| Jun 30, 2023 | 93 | - | - |
| Dec 31, 2021 | 83 | - | - |
| Sep 30, 2021 | 73 | - | - |
| Jun 30, 2021 | 61 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| TScan Therapeutics | 148 |
| InflaRx | 74 |
| BeyondSpring | 40 |
| Mereo BioPharma Group | 36 |
| eXoZymes | 31 |
| MediciNova | 13 |
| Actuate Therapeutics | 10 |
| Alterity Therapeutics | 9 |
GUTS News
- 16 days ago - Fractyl Health Completes Randomization in REMAIN-1 Pivotal Cohort of Revita® for Post-GLP-1 Weight Maintenance - GlobeNewsWire
- 5 weeks ago - Fractyl Health: Unreasonably Low Market Expectations Create A Trading Opportunity Towards 2026 Catalysts - Seeking Alpha
- 6 weeks ago - Fractyl Health, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – GUTS - Business Wire
- 6 weeks ago - Fractyl Health Shares Drop, Eyes New FDA Route For Its Lead Product - Benzinga
- 6 weeks ago - Fractyl Health, Inc. (GUTS) Discusses REMAIN-1 Midpoint Cohort Results on Revita for Weight Maintenance After GLP-1 Discontinuation Transcript - Seeking Alpha
- 6 weeks ago - Fractyl Health Announces Compelling 6-Month Randomized REMAIN-1 Midpoint Data Showing Durable Weight Maintenance with Revita® After GLP-1 Discontinuation - GlobeNewsWire
- 2 months ago - Fractyl Health Appoints Lara Smith Weber as Chief Financial Officer to Support Commercial-Stage Preparedness - GlobeNewsWire
- 2 months ago - Fractyl Health Enters a Catalyst-Rich 2026 Positioned to Define the Post-GLP-1 Weight Maintenance Therapeutic Category - GlobeNewsWire